Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Johnsson

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Lakartidningen|November 27, 2008
[Massive pulmonary embolism--not only a question of thrombolysis]Hans Johnsson
Lakartidningen|December 10, 2002
[An efficient department of radiology is a key to good diagnosis of venous thrombosis. However indications for insertion of vena cava filters are not yet certain]Hans Johnsson
Lakartidningen|November 25, 2004
[Surgery in acute pulmonary embolism can be a life-saving therapeutic alternative. A follow up of surgically treated patients]Johnny Steuer, Terbjörn Ivert, Hans Johnsson
Lakartidningen|February 26, 2010
[Prednisolone affects Waran medication]Bo Holmström, Hans Johnsson, Viveka Frykman
BMC Family Practice|April 5, 2003
Anticoagulant treatment in primary health care in Sweden - prevalence, incidence and treatment diagnosis: a retrospective study on electronic patient records in a registered populationGunnar H Nilsson, Ingela Björholt, Hans Johnsson
Lakartidningen|September 11, 2008
[Management of thrombocyte inhibitors prior to surgery. Too early withdrawal can result in severe risks for the patient]Michael Lagerkranser, Hans Johnsson, Karl Gösta Ljungström
Circulation|March 20, 2013
Letter by Hjemdahl et al regarding article, "Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial"Paul Hjemdahl, Hans Johnsson, N Håkan Wallén
Lakartidningen|December 17, 2009
[New drug in atrial fibrillation--how does it function in regular health care?]Margareta Holmström, Hans Johnsson, Gerd Lärfars, et al.
Biology of the Neonate|September 25, 2003
Hyaluronan in the human neonatal lung: association with gestational age and other perinatal factorsHans Johnsson, Lars Eriksson, Bengt Gerdin, et al.
Thrombosis and Haemostasis|March 11, 2010
The direct thrombin inhibitors (argatroban, bivalirudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysisShu He, Margareta Blombäck, Niklas Bark, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Lakartidningen|November 27, 2008
[Massive pulmonary embolism--not only a question of thrombolysis]Hans Johnsson
Lakartidningen|December 10, 2002
[An efficient department of radiology is a key to good diagnosis of venous thrombosis. However indications for insertion of vena cava filters are not yet certain]Hans Johnsson
Lakartidningen|November 25, 2004
[Surgery in acute pulmonary embolism can be a life-saving therapeutic alternative. A follow up of surgically treated patients]Johnny Steuer, Terbjörn Ivert, Hans Johnsson
Lakartidningen|February 26, 2010
[Prednisolone affects Waran medication]Bo Holmström, Hans Johnsson, Viveka Frykman
BMC Family Practice|April 5, 2003
Anticoagulant treatment in primary health care in Sweden - prevalence, incidence and treatment diagnosis: a retrospective study on electronic patient records in a registered populationGunnar H Nilsson, Ingela Björholt, Hans Johnsson
Lakartidningen|September 11, 2008
[Management of thrombocyte inhibitors prior to surgery. Too early withdrawal can result in severe risks for the patient]Michael Lagerkranser, Hans Johnsson, Karl Gösta Ljungström
Circulation|March 20, 2013
Letter by Hjemdahl et al regarding article, "Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial"Paul Hjemdahl, Hans Johnsson, N Håkan Wallén
Lakartidningen|December 17, 2009
[New drug in atrial fibrillation--how does it function in regular health care?]Margareta Holmström, Hans Johnsson, Gerd Lärfars, et al.
Biology of the Neonate|September 25, 2003
Hyaluronan in the human neonatal lung: association with gestational age and other perinatal factorsHans Johnsson, Lars Eriksson, Bengt Gerdin, et al.
Thrombosis and Haemostasis|March 11, 2010
The direct thrombin inhibitors (argatroban, bivalirudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysisShu He, Margareta Blombäck, Niklas Bark, et al.
Pageof 2